PEDIAPRED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pediapred, and when can generic versions of Pediapred launch?
Pediapred is a drug marketed by Seton Pharm and is included in one NDA.
The generic ingredient in PEDIAPRED is prednisolone sodium phosphate. There are eighty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pediapred
A generic version of PEDIAPRED was approved as prednisolone sodium phosphate by BAUSCH AND LOMB on July 29th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PEDIAPRED?
- What are the global sales for PEDIAPRED?
- What is Average Wholesale Price for PEDIAPRED?
Summary for PEDIAPRED
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 36 |
| Clinical Trials: | 6 |
| Patent Applications: | 5,152 |
| What excipients (inactive ingredients) are in PEDIAPRED? | PEDIAPRED excipients list |
| DailyMed Link: | PEDIAPRED at DailyMed |
Recent Clinical Trials for PEDIAPRED
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| CureRareDisease LLC | Phase 1/Phase 2 |
| Myrtelle Inc. | Phase 1/Phase 2 |
| Nancy Bauman | Phase 2 |
Pharmacology for PEDIAPRED
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for PEDIAPRED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seton Pharm | PEDIAPRED | prednisolone sodium phosphate | SOLUTION;ORAL | 019157-001 | May 28, 1986 | AA | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PEDIAPRED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Seton Pharm | PEDIAPRED | prednisolone sodium phosphate | SOLUTION;ORAL | 019157-001 | May 28, 1986 | 4,448,774 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
